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Serotonin Regulates Mammary Gland
Development via an Autocrine-Paracrine Loop
unexpected observation that the mammary gland ex-
presses the serotonin-biosynthetic enzyme tryptophan
hydroxylase (TPH). This discovery provoked a series of
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Zhaoyuan Hou,1 Meenakshi Mistry,1
Jason P. Bailey,1 Kathryn M. Nieport,1 physiological studies leading us to the conclusion that
the mammary glands possess an autocrine-paracrineDiego J. Walther,3 Michael Bader,3
and Nelson D. Horseman1,* serotonergic system that communicates important local
1Department of Molecular and Cellular Physiology homeostatic information.
2College of Pharmacy Serotonin (5-hydroxytryptamine, 5-HT) is a central
University of Cincinnati neurotransmitter that is widely implicated in the regula-
Cincinnati, Ohio 45221 tion of mood and cognition, and is a peripheral signaling
3 Max Delbru¨ck Center for Molecular molecule that affects hemostasis, immune function, in-
Medicine (MDC) testinal physiology, and other systems (Hardman and
Robert-Ro¨ssle` Strasse 10 Limbird, 2001). There are multiple types of 5-HT recep-
D-13092 Berlin-Buch tors that are distributed widely among endocrine, car-
Germany diovascular, immune, and gastrointestinal tissues. Re-
ceptors for 5-HT fall into one of four distinct families
(5-HTR1, 5-HTR2, 5-HTR3, 5-HTR4-7), which are character-
Summary ized by different signal transduction mechanisms and
physiological roles.
Mammary gland development is controlled by a dy- TPH is the rate-limiting enzyme for 5-HT synthesis
namic interplay between endocrine hormones and lo- (Fitzpatrick, 1999) and is encoded by both the classical
cally produced factors. Biogenic monoamines (seroto- TPH gene (TPH1) and a newly discovered neuronal gene
nin, dopamine, norepinephrine, and others) are an (TPH2), which is preferentially expressed in the brain
important class of bioregulatory molecules that have (Walther et al., 2003). The discovery of a dual genetic
not been shown to participate in mammary develop- basis for central and peripheral 5-HT biosynthesis,
ment. Here we show that mammary glands stimulated which is conserved in mammals, birds, and fish, sug-
by prolactin (PRL) express genes essential for seroto- gests that both neural and nonneural functions of 5-HT
nin biosynthesis (tryptophan hydroxylase [TPH] and have essential and distinct physiological roles.
aromatic amine decarboxylase). TPH mRNA was ele- Mammary gland development and lactation are regu-
vated during pregnancy and lactation, and serotonin lated by a dynamic interplay of endocrine and locally
was detected in the mammary epithelium and in milk. produced (autocrine-paracrine) factors. These signals
TPH was induced by PRL in mammosphere cultures conspire to facilitate both the dramatic changes neces-
and by milk stasis in nursing dams, suggesting that sary for development and lactogenesis (homeorrhesis)
the gene is controlled by milk filling in the alveoli. and the adjustments required to maintain the steady-
Serotonin suppressed -casein gene expression and state quality and quantity of milk during lactation (ho-
caused shrinkage of mammary alveoli. Conversely, meostasis). Prolactin (PRL) is the major endocrine in-
TPH1 gene disruption or antiserotonergic drugs re- ducer of mammopoiesis and milk secretion (Horseman,
sulted in enhanced secretory features and alveolar 1999; Vomachka et al., 2000). Nursing stimulates a reflex
dilation. Thus, autocrine-paracrine serotonin signaling secretion of PRL, which induces a variety of milk protein
is an important regulator of mammary homeostasis genes and secretory functions. A well-characterized
and early involution. PRL signaling pathway operates by activation of a non-
receptor tyrosine kinase (Jak2) and a latent transcription
Introduction factor (Stat5) (Groner and Gouilleux, 1995). A separate,
Stat5-independent signaling pathway involves arachi-
To discover potentially novel aspects of mammary gland donic acid mobilization, and this pathway appears to
physiology and development, we set out to identify be more important for stimulating milk secretion (Lkhider
genes for which expression is altered by prolactin (PRL). et al., 2001). Thus, lactation is driven by an endocrine
We focused our attention on discovering PRL-regulated signaling system that is strongly influenced by nursing
genes that do not encode milk proteins or other conven- activity and affects expression of milk genes and secre-
tional milk-associated gene products (Groner and Gouil- tory activity through multiple signal transducers.
leux, 1995; Hennighausen et al., 1997). The gene expres- An autocrine-paracrine homeostatic feedback op-
sion profiling studies we report here led us to the poses the endocrine stimulation of mammary develop-
ment and milk secretion. The feedback system has been
*Correspondence: nelson.horseman@uc.edu characterized by numerous physiological studies in ro-
4 These authors contributed equally to this work. dents and ruminants (Daniel and Smith, 1999). As milk
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tein gene expression is suppressed, and involution is6 Present address: National Institute of Radiological Sciences, 4-9-1
initiated (Peaker et al., 1998). In spite of the careful physi-Anagawa Inage-Ku, Chiba 263-8555, Japan.
ological characterization of the local feedback regula-7 Present address: Department of Biology, Arcadia University,
Glenside, Pennsylvania 19038. tion in the mammary gland, the specific biochemical
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components of this regulatory system have not been
identified.
Results
A Gene Encoding TPH Is Induced
in the Mammary Glands
Suppression subtractive hybridization cloning (Dia-
tchenko et al., 1996) was used to identify genes that
were differentially expressed in mammary gland tissues
from PRL-deficient (PRL/) mice (Horseman et al., 1997)
compared with mice made hyperprolactinemic by pitu-
itary grafting (18 days) and mice that were treated by
implanting progesterone-containing tablets (25 mg, 18
days). Pituitary grafting was used because it causes
sustained elevation of PRL without elevation of other
pituitary hormones (Adler, 1986). The level of PRL after
pituitary grafting was in the range of 50–150 g•ml1
(unpublished data), which results in substantial stimula-
tion of mammary gland development (similar to the latter
half of pregnancy). Of the several genes identified as
being PRL dependent, eight of an initial 25 clones that
we sequenced encoded cDNA fragments for tryptophan
hydroxylase (EC1.14.16.4, TPH, Genbank accession
Figure 1. TPH mRNA Is Expressed in Mouse and Human Mam-number: AF273257), which catalyzes the conversion of
mary Glandstryptophan to 5-hydroxytryptophan (5-HTP).
(A) Mammary gland mRNA was reverse transcribed and SouthernSeveral tests were done to confirm the induction of
blotted (virtual Northern blot) using alkaline phosphatase-labeledTPH by PRL in the mouse mammary gland. Differential
mouse TPH cDNA probe. The TPH signal was induced following 18hybridization to arrayed mouse cDNAs (Clontech Mouse
days treatment with pituitary grafting (lane 3) when compared with
Atlas version 1.2, Palo Alto, CA) revealed an induction progesterone-treated (lane 2) or sham-operated control (lane 1)
of TPH mRNA in PRL-stimulated breast, and the signal mice. The molecular sizes of the bands (kilobases, kb) are labeled
intensity indicated that the transcript was relatively in the right margin. Glyceraldehyde-3-phosphate dehydrogenase
(GPDH) is shown as an internal positive control.abundant in PRL-stimulated mammary gland (being
(B and C) In situ hybridization analysis of TPH in a pituitary graft-among the upper 10% of 1200 genes, data not shown).
stimulated (B) and unstimulated (C) mammary gland. AntisenseVirtual Northern blotting (Southern hybridization to full-
probe-specific signal (*) was observed in epithelial cells. Digoxy-
length cDNA) was used to identify the mammary TPH genin-labeled antisense cRNA probe corresponded to the 5 end of
transcripts (Figure 1A). TPH transcripts of 1.8 and 3.8 TPH mRNA (200 bases). The corresponding sense-strand probe
kilobases, which is in agreement with other nonneuronal was used as a negative control (data not shown).
(D) Human TPH mRNA was identified by RT-PCR in extracts oftissues (Stoll and Goldman, 1991), were detected in the
normal human breast (lanes 1 and 2) and brain (lanes 3 and 4) andmammary gland extracts after pituitary grafting but were
in human breast-derived epithelial cells, MCF-10A (lanes 5 and 6),undetectable in glands of control or progesterone-
and T47D (lanes 7 and 8). Controls (lanes 1, 3, 5, and 7) were from
treated mice. In the mouse mammary gland, in situ hy- RNA samples that were handled identically but without reverse tran-
bridization revealed that the TPH gene was expressed scription. Fragments with the expected size (confirmed by sequenc-
in the epithelial cells of pituitary-grafted but not control ing) were amplified from cDNA samples (lanes 2, 4, 6, and 8).
virgin mice (Figures 1B and 1C). The gene encoding TPH
was expressed in normal human breast and brain tissues
(total RNA, Stratagene, Inc., La Jolla, CA) and in both previously published report showing no melatonin syn-
nontransformed human breast epithelial cells (MCF10A) thesis in rat mammary glands (Chen et al., 1999). Mam-
and T47D human breast cancer cells (Figure 1D). mary TPH cDNA was amplified with primers specific for
the peripheral TPH1 isoform but not with TPH2-specific
primers (Figure 2B). The pattern of enzyme gene expres-Serotonergic Enzyme Gene Expression in Mouse
sion implied that the mammary gland can synthesizeMammary Glands
and secrete 5-HT. To test this, we performed two typesTPH converts L-tryptophan to 5-HTP, which is metabo-
of experiments: immunohistochemistry for 5-HT andlized to 5-HT by aromatic amine decarboxylase (AADC,
measurements of 5-HT in milk.EC4.1.1.28). In the pineal gland, 5-HT is converted to
melatonin through serotonin N-acetyltransferase (SNAT,
EC2.3.1.5). Representative results of assays for expres- Serotonin in the Mammary Epithelium and Milk
Immunoreactive 5-HT was localized specifically in thesion of the indoleaminergic enzymes are shown in Figure
2. TPH1 expression was highly induced by PRL, AADC epithelium of mammary glands from pituitary-grafted
female mice (Figures 2C and 2D). We also noted a lowmRNA was modestly, albeit consistently, elevated in
PRL-stimulated mammary extracts, and SNAT was not level of 5-HT staining in the adipose stroma. It was diffi-
cult to determine whether the stromal staining was spe-detected in the mammary glands (Figure 2A). The lack
of SNAT expression is consistent with results from a cific because of its low intensity and dispersion, but we
5-HT and Mammary Function
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Preliminary experiments showed that 5-HT was pres-
ent in milk expressed from the nipples of five mice (data
not shown), but it was difficult for us to collect sufficient
and consistent volumes of fresh milk from individual
mice, so we chose to study milk 5-HT by dialysis of
flowing duct milk in situ. To this end, main ducts of the
#4 glands of mice that were 4–9 days postpartum were
cannulated with dialysis probes, and 5-HT was mea-
sured in the dialysates by HPLC/EC (Raymond et al.,
1978; Shankaran and Gudelsky, 1999). The milk within
mammary gland ducts contained substantial quantities
of both 5-HT and its primary metabolic product, 5-HIAA.
The values we report here are from samples collected in
the second 30 min after oxytocin injection, and repeated
sampling of the dialysates showed that 5-HT was se-
creted into the milk for at least 1.5 hr. The concentrations
of 5-HT and 5-HIAA in milk were 16.0  4.5 ng•ml1 and
11.5  1.5 ng•ml1, respectively (n  6 mice). While it
is conceivable that 5-HT in the milk or epithelium could
be derived from a source other than the mammary gland,
the most parsimonious inference is that the primary
source of this 5-HT was the mammary epithelium. These
experiments established that the mammary gland ex-
presses the peripheral isoform of TPH and AADC and
that 5-HT is present in the mammary epithelium and
milk. Because TPH is the rate-limiting step in 5-HT syn-
thesis and appeared to be tightly regulated in mammary
glands, we undertook a series of experiments to study
TPH gene regulation.
TPH Gene Regulation In Vivo by Reproductive
Development, Hormones, and Milk Stasis
TPH and AADC mRNA levels were measured by real-
time RT-PCR in normal wild-type mice at various stages
of mammary gland development (Figure 3A). The highest
levels of TPH mRNA were observed in pregnant mice.
Figure 2. The Serotonin Biosynthetic System in the Mouse Mam- Low levels of TPH and AADC mRNA were observed in
mary Gland
nulliparous mice and during involution. On day 10 of
(A) Expression of mRNA for indoleamine-synthesizing enzymes was
lactation, TPH mRNA was intermediate between that inexamined by RT-PCR (see Supplemental Table S1 for primer se-
nulliparous and pregnant animals. RT-PCR with primersquences at http://www.developmentalcell.com/cgi/content/full/6/2/
specific for TPH1 and TPH2 demonstrated that the mam-193/DC1), and mRNAs for the two enzymes necessary for 5-HT
synthesis (TPH and AADC) were seen to be expressed in the mam- mary gland expresses exclusively TPH1 at all develop-
mary gland. In contrast, serotonin N-acetyl transferase mRNA mental stages (unpublished data). The higher levels of
(SNAT), which is necessary for melatonin synthesis, was not detect- TPH1 during pregnancy and lactation correspond with
able in mammary gland but was detected in the positive control
the elevation of lactogen (PRL or placental lactogens)tissue (pineal). Lane 1, control; lane 2, progesterone treated; lane
during these phases of development.3, pituitary grafted. Primers specific for the classical (TPH1) and
To study TPH regulation by intrinsic mammary glandneuronal (TPH2) isoforms of TPH were used to determine which
gene was expressed in the mammary gland (B). TPH1-specific but mechanisms, individual teats were sealed so that we
not TPH2-specific primers yielded an amplified product in mammary could compare TPH expression in suckled and unsuck-
gland tissue, whereas TPH2 was preferentially expressed in the led glands that were exposed to the same stimulatory
brain. (C) and (D) show immunostaining patterns for 5-HT in the
hormonal milieu (Li et al., 1997). Figures 3B and 3C showmammary gland. Paraffin sections of mouse mammary tissue taken
results from experiments in which TPH and milk proteinon day 18 after pituitary grafting were immunostained with mono-
mRNA levels were compared between #3 abdominalclonal anti-5-HT (C) or control IgG (D). Accumulation of 5-HT (lucent
signal) was detected in the mammary gland epithelium with a low mammary glands that were left open on one side (suck-
level of staining in the adipose stroma. led) while the contralateral gland was sealed (unsuck-
led). TPH mRNA was expressed in all the glands whether
they were open or sealed. However, the level of TPH
expression was consistently higher in the sealed glandshave observed 5-HT receptor gene expression in the
stroma (unpublished data), which suggests that some compared with their contralateral open controls. In con-
trast, milk protein gene expression was downregulatedof the apparent stromal staining could be accounted
for by receptor bound 5-HT. The epithelial cells were by teat sealing, and the housekeeping gene standard
(glyceraldehyde phosphate dehydrogenase, GPDH) wasuniformly positive, and the background in the epithelium
was very low. unaffected, as shown in representative electrophoretic
Developmental Cell
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Figure 3. Mammary TPH Regulation during Development and Lactation
(A) Levels of TPH mRNA were measured by real-time RT-PCR in mammary gland extracts from nulliparous (N), pregnant (P, day 15 postcoitus),
lactating (L, day 10 postpartum), and involuting (I, day 3 postweaning).
(B) Levels of expression for TPH, -casein, whey acidic protein (WAP), and GPDH were measured in extracts of #3 glands with open or sealed
teats 24 hr after sealing. Representative cDNA bands from RT-PCR assays showed that TPH was increased, whereas casein and WAP were
decreased, and GPDH was unaffected by teat sealing.
(C) For quantification, average levels of TPH expression were determined by densitometry in extracts from six mice in which one gland was
open and the other sealed. Values were normalized to GPDH and expressed as percent of the average level of the control (unsealed) glands
(mean  SEM). Open and sealed glands were compared by paired t test and were significantly different (*p  0.02, n  6).
patterns (Figure 3B). To make statistical comparisons cycloheximide, which blocks translation (data not shown).
Estradiol did not induce TPH expression above the PRL-of TPH expression, gel images were scanned and the
fluorescence intensities (relative to GPDH internal stan- stimulated level in the mammosphere cultures (Figure
4C). Progesterone caused a dose-dependent inhibitiondard) were averaged (Figure 3C). This test showed that
there was a statistically significant difference in TPH of PRL-stimulated TPH expression (Figure 4D).
mRNA comparing the open and sealed glands (two-
tailed, paired t test, p  0.02, n  6). Serotonergic Agents Affect Lobuloalveolar
Development in Mammary Explants
Unlike peptide hormones and growth factors, for whichTPH Gene Regulation in Three-Dimensional
Mammary Epithelial Cell Cultures there are very few drugs that have specific effects on
synthesis, release, or receptor activation, there are nu-We attempted to study TPH regulation using conven-
tional cell culture experiments with an established merous well-characterized agents that affect mono-
amine (e.g., serotonin) signal transduction at specificmouse mammary epithelial cell line (HC11) or enriched
primary mouse mammary epithelial cells (PMEC) cul- levels (Hardman and Limbird, 2001; Azmitia, 2001). The
effects of PRL and serotonergic agents were studied intured on plastic dishes, but these techniques produced
inconsistent results in which TPH was expressed only explants from midpregnant mouse mammary glands.
Figure 5 shows representative hematoxylin-eosin stainedat very low levels. To achieve a closer correspondence
between an in vitro model and the in vivo situation, sections through explants treated with PRL and seroto-
nergic agents. For comparisons with normal develop-we studied TPH regulation in mammosphere cultures.
Mammospheres develop when PMEC are suspended in ment, the reader is referred to the mammary histology
database (http://mammary.nih.gov). In the absence ofa semisolid medium such as reconstituted basement
membrane (Matrigel, BD Biosciences, Palo Alto, CA). PRL treatment, the control explants (Figure 5A) were
regressed to simple, largely tubular structures that hadUnder these conditions, PMEC form spherical, cystic
structures that are polarized so that the basolateral sur- a few small alveolar buds, compact cytoplasms, and
few, if any, secretory vesicles or lipid globules. Explantsfaces contact extracellular matrix proteins, and the api-
cal surfaces line a closed central lumen. These complex treated with PRL (Figure 5B) took on a highly stimulated
biosynthetic and secretory appearance. The epitheliumstructures, termed mammospheres, secrete milk pro-
teins, fluids, and ions vectorially into the lumen and formed lobuloalveolar clusters with dilated and filled
lumens. Individual cells had large nuclei and expandedrespond to lactogenic hormones (Blatchford et al.,
1995). Mammosphere TPH mRNA increased robustly for cytoplasms that were filled with basophilic material,
secretory vesicles, and lipid globules. The epitheliumat least 96 hr following additions of PRL to the medium
(Figure 4A). This time course was slower than is typical was reminiscent of that in actively lactating mammary
glands, although there was more adipose stroma in thefor genes that are regulated directly by PRL such as the
milk proteins, which indicated that a complex indirect PRL-stimulated explants than is typical of lactating
glands. When 5-HT was added along with PRL (Figureprocess might be involved in TPH induction by PRL.
The dose response for PRL (Figure 4B) was typical of 5C), the explants took on the appearance of involuting
glands. The alveoli were collapsed, and the cells hadmany PRL effects in mammary cells and other cell types.
Induction of TPH mRNA in mammospheres was blocked small clear cytoplasms. Many cells had dense, pych-
notic, and fragmented nuclei. Thus, even in the presenceby either actinomycin D, which blocks transcription, or
5-HT and Mammary Function
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Figure 4. Profiles of TPH mRNA Induction in
Primary Mouse Mammary Epithelial Cells
Cultured as Three-Dimensional Organoids
(A) TPH levels during 4 days of hormone treat-
ment (1 g•ml1 oPRL) are shown as repre-
sentative electrophoretic bands (above) and
as mean ( SEM) relative to the maximum
value (“1”) in the graph (n  4 experiments).
(B) A dose-response relationship for oPRL
concentrations (g•ml1) relative to the maxi-
mum induction is shown as representative
electrophoretic bands (above) and as means
( SEM) for four experiments (below). Cells
were cultured with the respective PRL con-
centrations for 48 hr.
(C) Representative RT-PCR results from two
experiments on the effects of estradiol (EB,
estradiol benzoate, 0.01, 0.1, 1.0 nM) in PRL-
treated cultures after 48 hr incubation with
hormones. Estradiol did not alter TPH mRNA
in vitro.
(D) Representative results from two experi-
ments showing that progesterone (Prog) in-
hibited PRL-stimulation of TPH mRNA in a
dose-dependent manner (0.1, 1, 10 nM, 0.1,
1 M). Cultures were treated for 48 hr with
PRL and progesterone or were untreated
(leftmost lane).
of PRL levels that otherwise would be stimulatory, 5-HT expression, we hypothesized that blocking 5-HT recep-
tors would enhance PRL-induced milk gene expressionsuppressed the secretory and biosynthetic activity of
the epithelium in mammary explants. The adipose stroma in mammospheres. Milk protein mRNA levels were as-
sayed in extracts of mammosphere cultures treated withalso appeared to be affected by 5-HT, with smaller lipid
globules and more fibrous stroma. Treatment with combinations of PRL and methysergide, an antagonist
of multiple 5-HT receptor subtypes. Methysergide in-p-chlorophenylalanine (PCPA), which inhibits TPA activ-
ity, resulted in a very distinctive morphological change creased the expression levels of multiple milk protein
mRNAs (Figure 6B), and the effects were highly robustcharacterized by highly chromophilic epithelia and
dense secretory material inside acinar clusters (Figure in replicate experiments. The induction by methysergide
was consistently greatest for GlyCAM-1 (more than 10-5D). In explants treated with methysergide (a 5-HT re-
ceptor antagonist) and PRL, the secretory features fold) and similar for -casein, WAP, and -lactalbumin
(2- to 3-fold). GPDH and the tight junction protein oc-within the epithelial cells and in the lumen were similar
to PRL but greatly exaggerated (Figure 5E). cludin were relatively unaffected by methysergide as
were other genes such as Na	-K	-ATPase and galacto-Lipid globules were counted to provide an objective
way of summarizing the morphological results (Figure syltransferase (data not shown).
5F). These data showed that 5-HT significantly (p 
0.001) inhibited the effect of PRL. PCPA treatment re- Serotonergic Agents Affect
Mammosphere Developmentsulted in levels similar to PRL alone, but the globules
were smaller on average with PCPA, so the counts may The foregoing experiments showed that 5-HT signaling
affected mammary morphology using intact tissue ex-not include small globules. Methysergide significantly
enhanced (p  0.001) the PRL effect on lipid globules. plants and that it affected gene expression in isolated
epithelial cultures. To test whether morphological devel-
opment was affected by 5-HT at the level of isolatedMilk Protein Gene Regulation
by Serotonergic Agents epithelial cells, mammoshere cultures were used.Under
control conditions (1% serum-containing medium), mam-The effect of 5-HT on PRL-induced -casein induction
was measured in monolayer cultures of primary mam- mospheres were small cystic structures comprising a
darker boundary layer surrounding a lighter interiormary epithelial cells (PMEC) (Figure 6A). Treatment of
PMEC with PRL for 24 hr induced a high level of -casein luminal space (Figures 7A and 7B). Qualitatively, those
treated with 5-HT (Figures 7C and 7D) had a distinctlygene expression. The induction of -casein was strongly
attenuated by 5-HT in a dose-dependent manner. Nei- different appearance with irregular diameters and re-
sembling solid ball-like structures or cysts with a smallther PRL nor 5-HT had any effect on GPDH expression.
The highest dose of 5-HT caused extinction of -casein lumen containing cell debris. PCPA treatment resulted
in dilated mammospheres with opaque, thin boundariesexpression, and the fact that housekeeping gene ex-
pression was unaffected indicated that the action of and strongly refractile luminal contents under phase
contrast (Figures 7E and 7F). Mammospheres treated5-HT could not be explained by nonspecific or toxic ef-
fects. with methysergide were similar in appearance to the
controls, with a light lumen and darker boundary layerHaving observed that 5-HT inhibited -casein gene
Developmental Cell
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Figure 5. Serotonergic Effects on Mammary
Gland Explant Cultures
Organ cultures of mammary glands from day
15 of pregnancy were cultured on floating
lens paper rafts (see Experimental Proce-
dures for details). Explants were treated with
combinations of PRL (1 g/ml) and either
5-HT, PCPA, or methysergide (2 
 104 M for
each), as labeled beneath each panel, for 10
days with medium changed every second
day. The explants were sectioned and stained
with hematoxylin and eosin and photo-
graphed with 60
objective magnification. (A)
shows control tissue, cultured in the pres-
ence of serum-free complete medium, con-
taining insulin, aldosterone, and hydrocorti-
sone (Ginsburg and Vonderhaar, 2000). (B)
shows a typical PRL-stimulated alveolar clus-
ter. Lipid globules are labeled (LG), and the
lumen contains amorphous secretory mate-
rial. (C) shows the effects of the combination
of PRL and 5-HT, and examples of pychnotic
nuclei (presumptive apoptotic figures) are la-
beled (PN). Note the paucity of secretory ma-
terial and lipid globules and the collapsed and
disorganized appearance of the alveolar clus-
ters. (D) shows a PCPA and PRL-treated ex-
plant with a cluster of acinar epithelial struc-
tures characterized by very densely staining
cytoplasms and dense secretory material. (E)
is from an explant that was treated by incuba-
tion with PRL and methysergide which shows
large lipid globules and exaggerated secre-
tory features. (F) shows tabulated counts for
lipid globules in each treatment group.
(Figures 7G and 7H), but the colonies treated with methy- difference in mammosphere size distribution was highly
significant (p  0.005; Mann-Whitney U test; Figure 7J).sergide appeared to be more dilated than the control
mammospheres.
We used an objective and quantitative morphometric TPH1 Gene Disruption Affects Mammary
method to determine the response of mammospheres Gland Development
to methysergide treatment because the effect of methy- Having established by physiological and pharmacologi-
sergide was less obvious than that of PCPA. The 5-HT- cal studies that TPH1 is expressed in the mammary
treated colonies had irregular crenated boundaries, so gland and that 5-HT signaling is inhibitory for mammary
morphometry was not done on these. Mammosphere development and gene expression, we made use of mice
size was measured by employing the Macintosh com- with a disruption of the TPH1 gene (Walther et al., 2003)
puter-based public domain NIH Image program (devel- to develop a genetic model in which to study mammary
oped at the U.S. National Institutes of Health and avail- TPH function. Based on our initial observation that TPH
able on the Internet at http://rsb.info.nih.gov/nih-image/). was highly induced by pituitary grafting (high PRL) but
Approximately 300 epithelial colonies in three replicate not by progesterone treatment, we asked whether mam-
experiments were measured for each group. The thresh- mary development in pituitary-grafted mice would be
olds were adjusted to outline automatically the mam- affected by TPH1 deficiency. The pharmacological stud-
mospheres, and they were sorted into frequency distri- ies led us to predict that the lobuloalveolar system would
butions based on colony sizes (in arbitrary units). The be more expansive and/or dilated in the TPH1/ back-
size distribution of colonies was plotted by histogram ground. This prediction was confirmed by analysis of
(Figure 7I), and these distributions were tested for signifi- stained histological sections of mammary glands from
cance by a nonparametric t test, which is summarized TPH1	/	 and TPH1/ mice (Figure 8A). Of particular
as a comparison of the median colony areas (Figure 7J). note, in both untreated and pituitary grafted TPH1/
The distribution of sizes was markedly shifted by drug females the ducts and alveolar sacs had larger luminal
treatment such that control colonies predominated diameters than the TPH1	/	 glands. The stimulated
among the smaller size classes (below 8 units), whereas TPH1/ glands were filled with secretory material (Fig-
methysergide-treated colonies were more frequent in ure 8Aiv). Although these data were consistent with the
in vitro studies showing direct actions of 5-HT in theall of the larger size classes (12 units and above). The
5-HT and Mammary Function
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Figure 6. Serotonergic Agents Alter Mammary Gland Gene Ex-
pression
(A) Primary mammary epithelial cells (PMEC) in monolayers were
cultured on rat tail collagen-coated plates in a 1% fetal bovine
serum-containing medium including insulin and EGF. After preincu-
bation for 7 days, the cells were treated with PRL either alone or in
combination with increasing doses of 5-HT for 48 hr (2, 20, 200
M). Expression levels of -casein and GPDH were assayed in RNA
extracts by RT-PCR.
(B) PMEC in three-dimensional mammosphere cultures were treated
with PRL (1 g•ml1) either alone or in combination with methyser-
gide (methy, 100 g•ml1), as shown above each lane. Expression
levels of -casein, WAP, GlyCAM-1. -lactalbumin, GPDH, and oc-
cludin were assayed in RNA extracts by RT-PCR. The data shown
for each panel are representative of three independent experiments.
mammary glands, it was possible that the hyperstimu-
lated phenotype of pituitary grafted TPH1/ mice could
result from effects on other tissues. To test this, we
analyzed mammary gland development in mice in which Figure 7. Effects of Serotonergic Agents on Cultured Mammospheres
selected teats were sealed to provoke stasis-induced
Mammospheres cultured from normal virgin (TPH	/	) mice were
involution (Figure 8B). The actively lactating glands with suspended in Matrigel and cultured in 1% fetal bovine serum-con-
open teats (Figures 8Bi and 8Biii) had complex lobulo- taining medium with addition of drugs, as described in Experimental
Procedures. Qualitative comparisons of typical mammospheres arealveoli surrounded by densely staining secretory epithe-
shown for cultures treated with control (A and B), 5-HT (C and D),lium. Typical of active lactation, the open glands had
PCPA (E and F), or methysergide (G and H). (A), (C), (E), and (G) arevery little adipose stroma. After 3 days in milk stasis, the
phase contrast images of mammosphere cultures in situ, and (B),
sealed glands of the normal (TPH1	/	) females showed (D), (F), and (H) are brightfield images of hematoxylin-eosin stained
signs of early involution, including collapse of the lobu- sections from paraffin-embedded mammospheres cultured identi-
loalveoli into clusters of regressing cells and extensive cally. (I) Frequency distributions of sizes of colonies for control-
(open bars) and methysergide-treated (closed bars) cultures. (J)reestablishment of the adipose stroma (Figure 8Bii). In
Median areas (in arbitrary units) of mammospheres sorted by sizecontrast, glands in the TPH1/ females were resistant
(n  350, two replicate experiments) of control- and methysergide-to stasis-induced involution (Figure 8Biv). The degree
treated cultures (p  0.005, Mann-Whitney U test).
of epithelial regression was variable but always less
than that in the TPH1	/	 controls, and there was no
detectable reestablishment of the adipose stroma after Discussion
3 days of stasis. These results in the TPH1 gene deletion
model were consistent with the physiological and phar- Mammary Expression of TPH and Regulation
macological studies, establishing that the mammary of 5-HT Synthesis
gland 5-HT biosynthetic system is an important compo- The mammary gland is known to synthesize a variety of
nent in the local control of development and secretory peptide growth factors, cytokines, and neuropeptides
(Daniel and Smith, 1999; Goldman and Frawley, 1996), butfunction.
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prior to our studies there was no evidence of biogenic
monoamine synthesis in mammary tissues. Knowing the
broad functional potential and ancient phylogenetic his-
tory of biogenic monoamine signaling, we suspected
that there might be important biological implications of
monoamine synthesis in the mammary glands. Conse-
quently, we performed a variety of experiments regard-
ing mammary 5-HT regulation and function.
The mammary glands are highly specialized skin
glands with an uncertain evolutionary history. Although
little data exist in mammalian skin, 5-HT is synthesized
in large amounts in skin glands of fish and amphibians
(Zaccone et al., 1994; Seki et al., 1995), suggesting that
monoamine synthesis may have been a primitive char-
acteristic in mammary gland evolution. Serotonin syn-
thesis has been documented in the skin of hamsters
(Slominski et al., 2002), but neither cells of origin nor
functions of integumentary 5-HT were studied in the
hamster. An unexpected duality in the 5-HT biosynthetic
system was recently demonstrated by the discovery of
a gene expressing a neuronal TPH isoform (TPH2), in
addition to the classical TPH1 gene, which is preferen-
tially expressed in peripheral tissues (Walther et al.,
2003). We observed that the peripheral TPH1 gene, but
not TPH2, was expressed in the mammary glands and
that it encoded two mRNA sizes (1.8 and 3.8 kb), which
may be accounted for by alternative mRNA processing
of the primary transcript.
TPH1 mRNA was elevated in mammary glands during
pregnancy and lactation compared with nulliparous vir-
gin and involuting glands. In lactating mice, the level of
TPH mRNA was doubled following 1 day of milk stasis
(teat sealing), which disrupts the normal homeostatic
balance between the extrinsic secretory drive (primarily
PRL) and local feedback. Identifying the specific mecha-
nisms by which TPH is induced by filling of the mammary
glands will be of interest.
Functions of Mammary TPH and 5-HT
Treatment of mammary gland explants or mammo-
spheres with 5-HT caused involution-related morpho-
logical changes. Conversely, inactivation of the 5-HT
pathway by gene disruption, a TPH blocker, or a 5-HT
receptor antagonist resulted in exaggeration of the de-Figure 8. Mammary Gland Phenotypes in TPH1/ Mice
velopmental changes associated with secretion. Be-(A) Hyperstimulation of TPH1/ mammary glands by PRL. Normal
cause these effects of serotonergic agents were similarTPH	/	 (Ai and Aii) and TPH1/ (Aiii and Aiv) mice were either un-
treated (Ai and Aiii) or PRL-stimulated by pituitary grafting (18 days; in both explants and mammospheres, they appear to
Aii and Aiv). In TPH	/	 mice, PRL stimulated the growth of clusters be mediated by 5-HT receptors on the epithelial cells.
of alveolar epithelium (Aii). TPH/ mice had open ducts with obvious Treatment of mammary epithelial cells with 5-HT sup-
secretory material in the unstimulated controls (Aiii) and responded
pressed PRL-induced -casein gene expression in ato PRL stimulation with exaggerated growth of alveolar clusters and
dose-dependent manner, which suggested that 5-HT inlarge amounts of dense secretory material in the lumens of alveoli
the immediate microenvironment of the epithelial cellsand ducts (Aiv).
(B) TPH1 gene disruption prevents normal stasis-induced involution. could function as an autocrine-paracrine regulator. In
Matched contralateral #4 glands from TPH	/	 (Bi and Bii) and TPH/ closed mammospheres, blocking 5-HT receptors per-
(Biii and Biv) mice were left open to suckling (Bi and Biii) or sealed mitted higher levels of expression for several milk pro-
(Bii and Biv) on day 10 of lactation. After 3 days of unilateral milk
tein genes, including -casein, WAP, -lactalbumin, andstasis, the glands were removed and prepared by histological sec-
GlyCAM1. Based on this pharmacological evidence, wetioning and staining. Involution-related changes in the normal mice
included collapse of the secretory lobuloalveoli into clusters of re- concluded that expression of specific mammary gland
gressing cells and extensive filling of the surrounding stroma with genes is restrained by activation of 5-HT receptors in
adipose fat (Bii). In contrast, TPH1/ glands retained an extensive the mammary epithelium. These initial studies have been
lobuloalveolar morphology without the normal adipose filling of the
limited to a few genes and pharmacological agents, butstroma (Biv).
there are many other mammary functions and a large
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Madison, WI); 100 ng of full-length cDNA was applied to each well ofvariety of available serotonergic drugs. Detailed and ex-
a 1.2% agarose gel, and Southern hybridization was done followingtensive pharmacological studies with a variety of sero-
manufacturer protocols for Hybond N	 membrane and Alkphos di-tonergic agonists and antagonists will be needed to
rect kit (APBiotech, Uppsala, Sweden). The tissue content of mouse
sort out the roles of 5-HT receptor signaling for specific TPH mRNA was measured by real-time quantitative RT-PCR (Kang
functions in the mammary glands. et al., 2000) using the Bio-Rad iCycler Thermal Cycler using SYBR-
Green detection with protocols recommended by the manufacturer.The recent establishment of TPH1 gene-disrupted
Primers are described in Supplemental Table S1 (see http://www.mice provided a valuable genetic model in which to test
developmentalcell.com/cgi/content/full/6/2/193/DC1).the roles of mammary 5-HT synthesis. Confirming all of
our physiological studies, TPH1/ mice were hyper-
In Situ Hybridization and Immunohistochemistryresponsive to PRL (pituitary grafting) and were resistant
Localization of TPH mRNA in mammary gland tissue sections was
to milk-stasis-induced involution. This animal model can performed as described in Hou et al. (2000). Ten micometers () para-
serve as the basis for a variety of future studies on the formaldehyde-fixed frozen sections were hybridized with digoxygenin-
role of mammary-derived 5-HT. labeled (DIG RNA Labeling Kit, Roche Molecular Biochemicals, India-
napolis, IN) sense and antisense RNA probe corresponding to 5The first phase of involution of the lobuloalveolar cells
end of TPH mRNA (200 bases). Immunohistochemical detectionmay occur while PRL levels are high. After PRL levels
of 5-HT was performed on 5  paraffin-embedded sections usingfall, the involution process enters a second phase char-
a monoclonal anti-5-HT (H209, Dako Corp., Carpinteria, CA), which
acterized by wholesale remodeling of the glands. Sev- was visualized by a Cy3-conjugated streptavidin-biotin secondary
eral of the local factors that mediate involution have antibody system (Histomouse SP, Zymed, Corp., South San Fran-
been identified. Our results suggest that the first phase cisco, CA).
of involution may be directly associated with 5-HT sig-
Assay of 5-HT and 5-HIAA in Milk Dialysatesnaling. Three other signaling molecules known to partici-
Microdialysis probes (2–4 mm length) were prepared and perfusedpate in the first phase of involution are transforming
as described previously in Yamamoto and Pehek (1990), and thegrowth factor- (TGF-), p53, and Stat3 (Chapman et
dialysate concentrations of 5-HT and 5-hydroxyindole acetic acid
al., 1999; Nguyen and Pollard, 2000). Future experiments (5-HIAA) were measured by high-pressure liquid chromatography
that link the pathways associated with these signaling with electrochemical detection (HPLC/EC) (Shankaran and Gudel-
molecules to 5-HT may provide valuable insights into sky, 1999). For collection of milk dialysate, the fourth inguinal mam-
mary gland was surgically exposed, and the main milk duct wasthe mechanisms of mammary development.
pierced with a 26 gauge needle to allow for insertion of the dialysisIn conclusion, our findings show that the mammary
probe. Oxytocin (0.2 IU intraperitoneal) was injected prior to probegland contains a complex serotonergic regulatory sys-
insertion to stimulate milk letdown. The dialysates were collected
tem that includes biosynthetic and functional compo- for 30 min intervals after discarding the first 30 min equilibration
nents. This autocrine-paracrine system appears to play samples. Levels of 5-HT and 5-HIAA were stable for at least 1 hr,
an important role in the processes of development and and the reported values are for the first 30 min sample. Recovery
efficiencies were determined to be approximately 1% from milk forhomeostatic control of lactation and involution.
5-HT and 5-hydroxyindole acetic acid (5-HIAA).
Experimental Procedures
Cell and Organ Explant Cultures
Animals Reagents and media for cell and organ cultures were purchased
Prolactin-deficient mice (Horseman et al., 1997), made congenic on from Life Technologies, Inc. (Gaithersburg, MD), unless otherwise
C57Bl/6J by eight backcross generations, were treated by either noted. PMEC were prepared from virgin mice (Swiss Black) by enzy-
grafting an anterior pituitary gland under the kidney capsule; im- matic digestion and differential trypsinization, modifying the method
planting a 25 mg, 21 day release progesterone tablet (Innovation of Imagawa et al. (2000). In brief, excised mammary glands were
Research of America, Sarasota, FL, USA) subcutaneously for 18 minced with a razor blade, transferred into 50 ml conical tubes, and
days; or were sham operated. Progesterone-treated tissues were digested in M199 medium containing bovine serum albumin (2.5
included in these experiments as a control so that we could distin- mg•ml1, fraction V, Sigma) and collagenase type III (0.1%, Worth-
guish genes that responded to PRL from those that were indirectly ington Biochemical Corporation, Freehold, NJ), penicillin-strepto-
regulated by PRL via its stimulatory effect on the ovary (Brisken mycin (1
 pen strep, 50 units•ml1-50 g•ml1, respectively), and
et al., 1999; Vomachka et al., 2000). Lactating female mice and amphotericin B (2 g•ml1, Sigma Chemical Co., St. Louis, MO) for
nulliparous virgin control mice were purchased from Harlan Labora- 3 hr at 37C. Organoids were allowed to settle, washed twice in
tories (Indianapolis, IN) and were studied between days 4 and 9 phosphate buffered saline, and incubated at 37C under 5% CO2 in
postpartum. Mice were maintained on an L, D: 14, 10 daily light, DMEM/F12 (1:1) containing insulin (5 g/ml), epidermal growth fac-
darkness cycle with food and water available ad libitum. Ovariec- tor (10 g•ml1), 1% fetal bovine serum (Harlan Bioproducts, India-
tomy was done via bilateral incisions in the flanks. Surgeries were napolis, IN), and 1
 pen strep (complete medium) for 5–7 days to
performed under general anesthesia and aseptic conditions. TPH/ let them attach to rat tail collagen-coated dishes (BD Biosciences,
and corresponding controls (TPH	/	) were mixed (129sv, C57BI /6) Palo Alto, CA). Fibroblasts were removed by four rounds of partial
genetic background. Mice were purchased for some studies from trypsinization. Resulting concentrated epithelial cells (2 
 105 cells
Jackson Laboratory (Bar Harbor, ME) or Taconic (Germantown, NY). per well) were plated on conventional plastic tissue culture dishes
All experiments were conducted under protocols that were ap- or on basement membrane (Matrigel, 1 ml per well, BD Biosciences,
proved by the Institutional Animal Care and Use Committee. Palo Alto, CA) reconstituted in a 6-well plate. They were preincu-
bated for 7 days in complete medium, which was changed each
day. After preincubation, the cells were treated with ovine PRL (1Differential Gene Expression
The cDNAs specifically expressed in the PRL-stimulated breast g•ml1) for 2 days. Following treatments, the cells were dissociated
with dispase (BD Biosciences, 150 units/well) and collected by cen-were cloned by suppression subtractive hybridization (Diatchenko
et al., 1996) using reagents and protocols from CLONTECH Labora- trifugation.
MCF10A cells are cultured on plastic dishes in medium containingtories, Inc. (Palo Alto, CA). Virtual Northern hybridization (Southern
hybridization to full-length cDNA) was performed following the man- DMEM/F12 with 5% horse serum, 10 g•ml1 insulin, 0.5 g•ml1
hydrocortisone, 1
 pen strep, 0.25 g•ml1 amphotericin B, 2 mMufacturer’s protocol (CLONTECH Laboratories, Inc.). Briefly, full-
length cDNA was prepared using the SMART primer method and L-glutamine, and 20 g•ml1 EGF. T47D cells were cultured on




 pen-strep, 0.25 g•ml1 amphotericin B, and 2 mM Takeda, K., Akira, S., Clarke, A.R., and Watson, C.J. (1999). Suppres-
sion of epithelial apoptosis and delayed mammary gland involutionL-glutamine.
Mammary gland explants were cultured according to the methods in mice with a conditional knockout of Stat3. Genes Dev. 13, 2604–
2616.outlined in Ginsburg and Vonderhaar (2000). Briefly, mammary
glands from pregnant C57Bl/6J mice (15 days postcoitus) were cul- Chen, A., Laskar-Levy, O., and Koch, Y. (1999). Selective expression
tured in Waymouth’s MB 752/1 medium (InVitrogen, Grand Island, of neuropeptides in the rat mammary gland: somatostatin gene is
NY); supplemented with L-glutamine (2 mM), penicillin (100 U•ml1), expressed during lactation. Endocrinology 140, 5915–5921.
streptomycin (100 g•ml1), gentamycin (50 g•ml1), 20 mM HEPES,
Daniel, C.W., and Smith, G.H. (1999). The mammary gland: a model5 g•ml1 insulin, 100 ng•ml1 aldosterone, 100 ng•ml1 hydocorti-
for development. J. Mammary Gland Biol. Neoplasia 4, 3–8.sone, and fatty acid free bovine serum albumin (1 mg•ml1); and were
Diatchenko, L., Lau, Y.F., Campbell, A.P., Chenchik, A., Moqadam,floated at the medium interface on siliconized lens paper rafts. The
F., Huang, B., Lukyanov, S., Lukyanov, K., Gurskaya, N., Sverdlov,cultures were maintained in a humidified atmosphere of 50% O2,
E.D., and Siebert, P.D. (1996). Suppression subtractive hybridization:5% CO2, and 45% N2 at 37C. Agents were added fresh every second
a method for generating differentially regulated or tissue-specificday, and the cultures were carried out for 10 days in total.
cDNA probes and libraries. Proc. Natl. Acad. Sci. USA 93, 6025–Drugs (methysergide, 5-HT, PCPA) were used over a dose range
6030.of 2 
 104 M – 2 
 107 M and did not have any negative effects
on cell viability or expression of housekeeping genes relative to Fitzpatrick, P.F. (1999). Tetrahydropterin-dependent amino acid hy-
untreated cells. These doses of drugs were in the same range as droxylases. Annu. Rev. Biochem. 68, 355–381.
previous studies of nonneuronal tissues in vitro (Tamura et al., 1996; Ginsburg, E., and Vonderhaar, B.K. (2000). Whole organ culture of
Tuladhar et al., 2000). Where a single dose is shown, the results the mouse mammary gland. In Methods in Mammary Gland Biology
represent the maximum dosage. and Breast Cancer Research, M.M. Ip and B.B. Asch, eds. (New
York: Kluwer Academic Publishers), pp. 147–154.
Histology Goldman, A.S., and Frawley, S. (1996). Bioactive components of
For histological examination, tissues or mammospheres were fixed milk. J. Mammary Gland Biol. Neoplasia 1, 241–242.
in 10% neutral buffered formalin, embedded in paraffin, sectioned
Groner, B., and Gouilleux, F. (1995). Prolactin-mediated gene activa-at 7 (tissue) or 4 (mammospheres), and stained with conventional
tion in mammary epithelial cells. Curr. Opin. Genet. Dev. 5, 587–594.hematoxylin-eosin reagents (Pathology Department, University of
Hardman, J.G., and Limbird, L.E. (2001). Goodman and Gilman’s TheCincinnati). Mammary gland wholemounts were as described in
Pharmacological Basis of Therapeutics (New York: McGraw-Hill).Horseman et al. (1997). Lipid globules were quantified by establish-
ing a threshold size (2 ) and counting globules that were larger Hennighausen, L., Robinson, G.W., Wagner, K.-U., and Liu, X. (1997).
than the threshold within multiple high power fields using images Prolactin signaling in mammary gland development. J. Biol. Chem.
captured by a digital camera. Averages were calculated for three 272, 7567–7569.
separate samples in each group, which were compared by ANOVA
Horseman, N.D. (1999). Prolactin and mammary gland development.
with Dunnett’s multiple comparison test.
J. Mammary Gland Biol. Neoplasia 4, 79–88.
Horseman, N.D., Zhao, W., Montecino-Rodriguez, E., Tanaka, M.,
Statistics and Experimental Replication
Nakashima, K., Engle, S.J., Smith, F., Markoff, E., and Dorshkind,
Each experiment in cultured cells and tissues was replicated two
K. (1997). Defective mammopoiesis, but normal hematopoiesis, in
to four times as noted, and representative results are shown in
mice with a targeted disruption of the prolactin gene. EMBO J.
the figures. Differences between means were tested by ANOVA for
16, 6926–6935.
multiple groups. For comparison of two means, Student’s t test (two
Hou, Z., Bailey, J.P., Vomachka, A.J., Matsuda, M., Lockefeer, J.A.,tailed) or an equivalent nonparametric test (Mann-Whitney U test)
and Horseman, N.D. (2000). Glycosylation-dependent cell adhesionwas used. Significance was accepted for p  0.05.
molecule 1 (GlyCAM 1) is induced by prolactin and suppressed by
progesterone in mammary epithelium. Endocrinology 141, 4278–
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